We performed knockdown studies in prostate cancer cells using siRNA against all three factors (siOSN) and confirmed downregulation of the cardinal biomarkers of prostate cancer progression (PSA and KLK2) in FM (Fig. S7A). The gene discussed is KLK3; the disease is Familial prostate cancer.